Historically drug pressure from SP drove the sequential mutations in dhfr and dhps, but continued pressure from some SP use and activity against malaria parasites by co-trimoxazole (trimethoprim-sulfamethoxazole) may have impacted the prevalence of these mutations [32]. This evidence concerns the gene DHFR and malaria.